Zobrazeno 1 - 10
of 51
pro vyhledávání: '"César Gómez Raposo"'
Autor:
Isabel Álvarez, Ángel Guerrero-Zotano, Josefina Cruz, Purificación Martínez, María Hernández, César A Rodríguez, Álvaro Rodríguez-Lescure, Silvia Antolín, Encarna Adrover, Raquel Andrés, Catalina Falo, Jose Ignacio Chacón, Ana Miguel, Sonia Servitja, Maria Galán Gramaje, Mireia Margelí Vila, César Gómez Raposo, María Jose Echarri, Rafael Villanueva, Ariadna TIbau Martorell, Silvia Varela Ferreiro, Ruth Campo, Juan Jose Miralles, Susana Bezares, Federico Rojo, Sara López-Tarruella
Publikováno v:
Cancer Research. 82:P1-15
Background: The RegistEM study is a non-interventional study that is providing prospective data from around 1900 ABC pts (females and males) diagnosed with advanced disease between 01/Jan/2016 and 31/Dec/2019, either after recurrence or at 1st diagno
Autor:
Miriam López-Gómez, Belén García de Santiago, Pedro-David Delgado-López, Eduardo Malmierca, Jesús González-Olmedo, César Gómez-Raposo, Carmen Sandoval, Pilar Ruiz-Seco, Nora Escribano, Jorge Francisco Gómez-Cerezo, Enrique Casado
Publikováno v:
World Journal of Meta-Analysis. 9:505-521
Autor:
Jesús Herranz, Jose Juan Illarramendi, Sara López-Tarruella, Isabel Alvarez, Catalina Falo, Purificación Martínez, Antonio Antón, Angel Guerrero-Zotano, Josefina Cruz, Diego Malón, Álvaro Rodríguez-Lescure, Raquel Andrés, Carlos Jara, César A. Rodríguez, Rosalia Caballero, Silvia Antolín, César Gómez-Raposo, Susana Bezares, Federico Rojo, Vega Iranzo, José Luis Alonso, Mireia Margeli, Encarna Adrover
Publikováno v:
Cancer Research. 81:PS5-22
Background: The RegistEM is a non-interventional cohort study enrolling 1,867 patients (pts) (males or females) with advanced breast cancer diagnosed from January 2016 to December 2019, either after recurrence or as first diagnosis, in 38 Spanish sit
Autor:
Enrique Casado, Francisco Zambrana Tevar, Juan Moreno-Rubio, César Gómez-Raposo, Belén García De Santiago, Alicia Martínez Hernández, Israel Thuissard-Vasallo, Ana M. Jimenez Gordo, Miriam López-Gómez, I. Iglesias, Fernando Neria, Pedro David Delgado-López
Publikováno v:
In Vivo
Aim To determinate molecular changes in the downstream epidermal growth factor receptor signaling pathway using serial liquid biopsies in patients with metastatic colorectal tumors (mCRC) under anti-angiogenic treatment. Patients and methods Determin
Autor:
José Antonio López-Guerrero, Marta Mendiola, José Alejandro Pérez-Fidalgo, Ignacio Romero, Ana Torres, Delia Recalde, Elena Molina, César Gómez-Raposo, Ana M. Levin, Ana Herrero, Jesús Alarcón, Carmen Esteban, Gloria Marquina, María Jesús Rubio, Eva Guerra, Luisa Sánchez-Lorenzo, Fernando Gálvez-Montosa, Ana de Juan, Cristina Churruca, Alejandro Gallego, Antonio González-Martín
Publikováno v:
Cancers; Volume 14; Issue 8; Pages: 1965
Cancers
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Consejo Superior de Investigaciones Científicas (CSIC)
Cancers
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Consejo Superior de Investigaciones Científicas (CSIC)
Simple Summary This is a collaborative approach between two multicentre structures, the Spanish Group of Ovarian Cancer Research (GEICO) and the Spanish Biobank Network (RNBB), for collecting high-quality clinical data and associated biospecimens fro
Publikováno v:
Cancer chemotherapy and pharmacology. 85(3)
The role of adjuvant chemotherapy (CT) is controversial in endometrial carcinoma (EC). Surgery alone is usually curative for women who are at a low risk of disease recurrence. The treatment of EC following surgical staging is based on the risk of rel
Autor:
Sagrario García Sánchez, Juan Moreno Rubio, César Gómez-Raposo, María Sereno, Francisco Zambrana Tébar, Rebeca Hernández Jusdado, Sandra Falagan, Victor Moreno, Enrique Casado Sáenz
Publikováno v:
Anti-Cancer Drugs. 26:1004-1007
Lung adenocarcinoma includes recurrent activating oncogenic mutations (EGFR, EML4-ALK, ROS1) that have been associated with response to EGFR and ALK inhibitors. Platinum-based chemotherapy is the standard therapy for non-oncodrivers population. Soraf
Autor:
Enrique Casado, Ines Suarez-Garcia, Paloma Cejas, D. Fernández-Luengas, César Gómez-Raposo, Jaime Feliu, Rosario Madero, Ana Maria Jimenez, Francisco Zambrana, Miriam López-Gómez, Juan Moreno-Rubio, María Merino, María Sereno
Publikováno v:
Clinical and Translational Oncology. 17:322-329
Treatment of metastatic colorectal cancer (mCRC) is generally based on genetic testing performed in primary tumor biopsies, but whether the genomic status of primary tumors is identical to that of metastases is not well known. We compared the gene ex
Autor:
César Gómez-Raposo, María Sereno, Jaime Feliu, D. Fernández-Luengas, Miriam López-Gómez, Rosario Madero, Ines Suarez-Garcia, Francisco Zambrana, María Merino, Enrique Casado, Ana Maria Jimenez, Juan Moreno-Rubio, Paloma Cejas
Publikováno v:
Clinical and Translational Oncology. 17:133-138
Colorectal liver metastases (CLM) have significant molecular heterogeneity, which contributes to the risk of recurrence following surgery. Most of the traditional scores intended to predict recurrence is based on clinicopathological variables and it
Autor:
María Sereno, Enrique Casado, Maria Merino-Salvador, Francisco Zambrana Tébar, César Gómez-Raposo, Cristina Rodríguez-Antona, Miriam López-Gómez, Gerardo Gutiérrez-Gutiérrez
Publikováno v:
Critical Reviews in Oncology/Hematology. 89:166-178
Oxaliplatin is one of the main drugs used in digestive tumors treatment. Peripheral neuropathy is a well-recognized dose-limiting toxicity of OXL. Two types of neuropathy have been described with this agent: acute or transient and chronic or persiste